A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
NAVAMEDIC operates in the Medical - Distribution industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 50M | 50M | 49M | 40M | 32M | 22M |
| Net Income | -513K | -513K | -1.3M | 3.1M | 72K | -1.8M |
| EPS | $-0.03 | $-0.03 | $-0.08 | $0.18 | $0.00 | $-0.12 |
| Free Cash Flow | 3.7M | 3.7M | 207K | 1.9M | 151K | -339K |
| ROIC | 14.0% | 8.1% | 6.9% | 19.3% | 7.2% | -3.3% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.53 | 0.71 | 0.22 | 0.29 | 0.19 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 3.0M | 3.0M | 2.2M | 4.7M | 1.3M | -526K |
| Operating Margin | 6.0% | 6.0% | 4.6% | 11.6% | 4.1% | -2.3% |
| ROE | -2.5% | -2.6% | -6.3% | 15.6% | 0.5% | -12.7% |
| Shares Outstanding | 17M | 17M | 17M | 17M | 15M | 14M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 22M | 32M | 40M | 49M | 50M | 50M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -526K | 1.3M | 4.7M | 2.2M | 3.0M | 3.0M |
| Op. Margin | -2.3% | 4.1% | 11.6% | 4.6% | 6.0% | 6.0% |
| Net Income | -1.8M | 72K | 3.1M | -1.3M | -513K | -513K |
| Net Margin | -7.8% | 0.2% | 7.7% | -2.7% | -1.0% | -1.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | -3.3% | 7.2% | 19.3% | 6.9% | 8.1% | 14.0% |
| ROE | -12.7% | 0.5% | 15.6% | -6.3% | -2.6% | -2.5% |
| ROA | -6.3% | 0.2% | 7.8% | -2.9% | -1.1% | -1.2% |
| Cash Flow | ||||||
| Op. Cash Flow | -339K | 151K | 1.9M | 207K | 3.7M | 3.7M |
| Free Cash Flow | -339K | 151K | 1.9M | 207K | 3.7M | 3.7M |
| Owner Earnings | -505K | -101K | 1.6M | -108K | 3.3M | 3.3M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 166K | 253K | 250K | 315K | 399K | 399K |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 166K | 253K | 250K | 315K | 399K | 399K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 561K | 0 | 996K | 5.2M | 3.0M | 3.0M |
| Balance Sheet | ||||||
| Net Debt | -1.6M | -1.1M | -870K | 10M | 7.2M | -3.5M |
| Cash & Equiv. | 4.2M | 6.1M | 5.8M | 3.6M | 3.5M | 3.5M |
| Long-Term Debt | N/A | N/A | N/A | 9.1M | 7.4M | 7.4M |
| Debt/Equity | 0.19 | 0.29 | 0.22 | 0.71 | 0.53 | 0.00 |
| Interest Coverage | -1.3 | 2.6 | 13.0 | 1.6 | 1.9 | 1.9 |
| Equity | 14M | 18M | 22M | 19M | 20M | 20M |
| Total Assets | 28M | 38M | 40M | 48M | 44M | 44M |
| Total Liabilities | 14M | 21M | 18M | 29M | 23M | 23M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -3.1M | -3.1M | 687K | -2K | 502K | 502K |
| Working Capital | 1.3M | 8.1M | 12M | 2.0M | 5.5M | 5.5M |
| Current Assets | 13M | 24M | 26M | 20M | 19M | 19M |
| Current Liabilities | 11M | 16M | 13M | 18M | 13M | 13M |
| Per Share Data | ||||||
| EPS | -0.12 | 0.00 | 0.18 | -0.08 | -0.03 | -0.03 |
| Owner EPS | -0.03 | -0.01 | 0.10 | -0.01 | 0.19 | 0.19 |
| Book Value | 0.96 | 1.14 | 1.31 | 1.13 | 1.16 | 1.16 |
| Cash Flow/Share | -0.02 | -0.01 | 0.11 | 0.01 | 0.21 | -0.01 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 14.4M | 15.4M | 16.8M | 17.3M | 17.5M | 17.5M |
| Valuation | ||||||
| P/E Ratio | -18.1 | 631.9 | 19.4 | -48.0 | -77.8 | -671.9 |
| P/FCF | N/A | 300.4 | 31.4 | 301.4 | 10.8 | 93.6 |
| EV/EBIT | N/A | 33.3 | 12.5 | 32.5 | 15.8 | 114.7 |
| Price/Book | 2.3 | 2.6 | 2.7 | 3.2 | 2.0 | 17.0 |
| Price/Sales | 1.4 | 1.4 | 1.5 | 1.3 | 0.8 | 6.9 |
| FCF Yield | -1.1% | 0.3% | 3.2% | 0.3% | 9.2% | 1.1% |
| Market Cap | 32M | 45M | 59M | 62M | 40M | 345M |
| Avg. Price | 2.06 | 2.78 | 3.26 | 3.53 | 3.01 | 19.75 |
| Year-End Price | 2.20 | 2.94 | 3.51 | 3.61 | 2.29 | 19.75 |
NAVAMEDIC passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 93.6x vs a median of 21.1x. The company's 5-year average ROIC is 7.6%. At current prices, the estimated annualized return to fair value is +78.1%.
NAVAMEDIC (NAVA-OL) has a 5-year average return on invested capital (ROIC) of 7.6%. This is below average and may indicate limited pricing power.
NAVAMEDIC (NAVA-OL) has a market capitalization of $345M. It is classified as a small-cap stock.
NAVAMEDIC (NAVA-OL) does not currently pay a regular dividend.
NAVAMEDIC (NAVA-OL) operates in the Medical - Distribution industry, within the Healthcare sector.
NAVAMEDIC (NAVA-OL) reported annual revenue of $50 million in its most recent fiscal year, based on SEC EDGAR filings.
NAVAMEDIC (NAVA-OL) has a net profit margin of -1.0%. The company is currently unprofitable.
NAVAMEDIC (NAVA-OL) generated $4 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
NAVAMEDIC (NAVA-OL) has a debt-to-equity ratio of 0.53. This indicates moderate leverage.
NAVAMEDIC (NAVA-OL) reported earnings per share (EPS) of $-0.03 in its most recent fiscal year.
NAVAMEDIC (NAVA-OL) has a return on equity (ROE) of -2.6%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 5 years of financial data for NAVAMEDIC (NAVA-OL), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NAVAMEDIC (NAVA-OL) has a book value per share of $1.16, based on its most recent annual SEC filing.
No recent press releases.